World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00934505
Date of registration: 07/07/2009
Prospective Registration: No
Primary sponsor: Centre Henri Becquerel
Public title: Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma RTEP3
Scientific title: Predictive Value of FDG-TEP During Exclusive Chemo-Radiotherapy (CRT) in Patients With Oesophageal Carcinoma Cancer on the One-Year Survival (RTEP3)
Date of first enrolment: May 2009
Target sample size: 100
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00934505
Study type:  Observational
Study design:  Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     VERA Pierre, MD phD
Address: 
Telephone:
Email:
Affiliation:  CHBecquerel
Name:     MICHEL Pierre, MD phD
Address: 
Telephone:
Email:
Affiliation:  CHRU Rouen
Name:     THILLAYS Marc, RT
Address: 
Telephone: 0033232082497
Email: marc.thillays@touen.fnclcc.fr
Affiliation: 
Name:     THILLAYS Marc, RCA
Address: 
Telephone: 00330232082497
Email: marc.thillays@rouen.fnclcc.fr
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Carcinoma épidermoïde of the oesophagus histologically proved, UICC Stage II B, III
or IVa (TNM on 2002)

- Decision of treatment by radio concomitant chemotherapy (radiotherapy in classic
spreading of 50Gy associated with a platinum chemotherapy.

Exclusion Criteria:

- Presence of a second evolutionary cancer in the previous three years

- index of performance OMS > 2

- Patients badly balanced diabetics



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Oesophageal Cancer
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
CHB08-02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history